Skip to content
中文产业新闻评分70Chinese source

ArriVent伏美替尼FURVENT三期一线治疗EGFR exon20ins NSCLC未达主要终点

全球‌Ⅲ‌期临床试验失败,国产超级大药出海不顺

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.